Sansure Biotech Inc.

XSSC:688289 Stock Report

Market Cap: CN¥12.8b

Sansure Biotech Future Growth

Future criteria checks 5/6

Sansure Biotech is forecast to grow earnings and revenue by 34.2% and 26% per annum respectively. EPS is expected to grow by 34.3% per annum. Return on equity is forecast to be 6.7% in 3 years.

Key information

34.2%

Earnings growth rate

34.3%

EPS growth rate

Medical Equipment earnings growth26.5%
Revenue growth rate26.0%
Future return on equity6.7%
Analyst coverage

Low

Last updated30 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:688289 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,468581N/A2041
12/31/20252,009448N/A1211
12/31/20241,496323N/A-1081
9/30/20241,407259-150203N/A
6/30/20241,296429-23697N/A
3/31/20241,203385-29936N/A
12/31/20231,007364-34844N/A
9/30/20233,0156386171,161N/A
6/30/20234,1889049731,523N/A
3/31/20235,2061,3451,3871,890N/A
12/31/20226,4501,9372,0002,559N/A
9/30/20225,3162,0841,2551,673N/A
6/30/20225,1762,2471,5511,963N/A
3/31/20224,7912,2721,6332,121N/A
12/31/20214,5152,2431,5041,877N/A
9/30/20214,4252,3612,0502,316N/A
6/30/20214,6912,5062,1752,404N/A
3/31/20215,5263,0462,6682,801N/A
12/31/20204,7632,6172,5342,642N/A
9/30/20203,7272,0341,7811,830N/A
6/30/20202,2991,2631,0971,150N/A
3/31/2020683233170203N/A
12/31/201936539-1222N/A
12/31/20183037-2310N/A
12/31/2017225-11N/A-61N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688289's forecast earnings growth (34.2% per year) is above the savings rate (2.8%).

Earnings vs Market: 688289's earnings (34.2% per year) are forecast to grow faster than the CN market (26.1% per year).

High Growth Earnings: 688289's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688289's revenue (26% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 688289's revenue (26% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 688289's Return on Equity is forecast to be low in 3 years time (6.7%).


Discover growth companies